5 studies found for:    "Collecting duct carcinoma"
Show Display Options
Rank Status Study
1 Recruiting Study of Gemcitabine+Platinium Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (BEVABEL)
Condition: Collecting Duct Carcinoma (Kidney)
Intervention: Drug: Bevacizumab
2 Active, not recruiting Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
Condition: Renal Cell Carcinoma
Interventions: Drug: Sorafenib;   Drug: Gemcitabine;   Drug: Cisplatin
3 Recruiting Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer
Conditions: Carcinoma of the Collecting Ducts of Bellini;   Chromophobe Renal Cell Carcinoma;   Kidney Medullary Carcinoma;   Kidney Oncocytoma;   Papillary Renal Cell Carcinoma;   Recurrent Renal Cell Carcinoma;   Sarcomatoid Renal Cell Carcinoma;   Stage IV Renal Cell Cancer
Intervention: Drug: Pazopanib Hydrochloride
4 Active, not recruiting Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
Condition: Kidney Cancer
Interventions: Drug: Everolimus;   Drug: Sunitinib
5 Completed
Has Results
Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer
Conditions: Renal Cell Cancer;   Kidney Cancer
Intervention: Drug: Sunitinib Malate

Indicates status has not been verified in more than two years